![glp-1 receptor agonist type 1 diabetes trial liraglutide agonists review and effects glp-1_analogs [TUSOM | Pharmwiki]](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=969476935847345)
glp-1 receptor agonist type 1 diabetes trial liraglutide agonists review and effects glp-1_analogs [TUSOM | Pharmwiki]
Description
Do GLP-1 drugs really lower inflammation
![glp-1 receptor agonist type 1 diabetes trial liraglutide agonists review and effects glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
17,499,500,501,502,503 Insulin resistance, a common occurrence in NASH patients, is a key driver of the diseases progression
![glp-1 receptor agonist type 1 diabetes trial liraglutide agonists review and effects glp-1_analogs [TUSOM | Pharmwiki]](https://www.nejm.org/cms/asset/5a8adb51-77d5-4c26-82b1-329fa8ad932a/nejmoa1411892_f1.jpg)
Phase 2 Trials The findings of phase 1 studies supported the continued clinical development of retatrutide as a promising candidate for the treatment of obesity and T2D
![glp-1 receptor agonist type 1 diabetes trial liraglutide agonists review and effects glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S0753332218327537-gr1.jpg)
Novak P, Pimentel Maldonado DA, Novak V
![glp-1 receptor agonist type 1 diabetes trial liraglutide agonists review and effects glp-1_analogs [TUSOM | Pharmwiki]](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3554075609853712195)
